Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cortisol synthesis is the metabolic process by which cholesterol is converted to cortisol, a glucocorticoid hormone, in the zona fasciculata of the adrenal cortex. This pathway involves several key cytochrome P450 enzymes (CYP11A1, CYP17A1, CYP21A2, CYP11B1), regulated by the hypothalamic-pituitary-adrenal axis (CRH → ACTH → adrenal cortex). The synthesized cortisol regulates diverse physiological responses including stress adaptation, glucose metabolism, immune modulation, and maintenance of homeostasis. Abnormal cortisol synthesis contributes to several endocrine and metabolic diseases, and thus, enzymes within this pathway are important pharmacological targets. For structure, the relevant therapeutic targets are the specific steroidogenic enzymes, not the overall process. Therefore, for precise targeting, refer to a key enzyme (e.g., "Cytochrome P450 11β-hydroxylase (CYP11B1)") rather than "cortisol synthesis".
Enzyme inhibition (e.g., inhibition of specific cytochrome P450 enzymes) Decreased production of cortisol Direct destruction of adrenal tissue (mitotane) Negative feedback suppression via exogenous glucocorticoids
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cortisol synthesis.